Makefield Therapeutics, Inc.
City: Newtown
Website: www.makefieldtherapeutics.com
Continue pre-clinical testing toward commercializing Makefield’s innovative, proprietary, nanoparticle-based drug delivery platforms. The company has begun two development efforts in applications that offer extensive market opportunities, with the potential to generate a pipeline of additional medications. The first program is in anti-infectives, therapeutics in which drug resistance is a critical and growing problem in both community and hospital settings. Infections caused by antibiotic-resistant bacteria can be severe, rapidly spreading, and life-threatening, and currently represent a significant burden to worldwide healthcare systems.